The IL-23R and Its Genetic Variants: A Hitherto Unforeseen Bridge Between the Immune System and Cancer Development

Overview

Journal Cancers (Basel)

Publisher MDPI

Date 2025 Jan 11

PMID 39796684

Authors

Salvatore Audia

Carolina Brescia

Vincenzo Dattilo

Naomi Torchia

Francesco Trapasso

Rosario Amato

Affiliations

Soon will be listed here.

Abstract

IL-23R (interleukin-23 receptor), found on the surface of several immune cells, plays a key role in the immune system. Indeed, this process is not limited to the inflammatory response but also plays a role in the adaptive immune response. The binding between IL-23R and its specific ligand, the interleukin 23, initiates a number of specific signals by modulating both properties and behavior of immune cells. In particular, it is critical for the regulation of T helper 17 cells (Th17). Th17s are a subset of T cells involved in autoimmune and inflammatory diseases, as well as in cancer. The clinical relevance of IL-23R is underscored by its association with an elevated susceptibility or diminished vulnerability to a spectrum of diseases, including psoriasis, ankylosing spondylitis, and inflammatory bowel disease (IBD). Evidence has emerged that suggests it may also serve to predict both tumor progression and therapeutic responsiveness. It is noteworthy that the IL-23/IL-23R pathway is emerging as a promising therapeutic target. A number of biologic drugs, such as monoclonal antibodies, are currently developing with the aim of blocking this interaction, thus reducing inflammation. This represents a significant advancement in the field of medicine, offering new hope for pursuing more effective and personalized treatments. Recent studies have also investigated the role of such a pathway in autoimmune diseases, and its potential impact on infections as well as in carcinogenesis. The aim of this review is to focus on the role of IL-23R in immune genetics and its potential for modulating the natural history of neoplastic disease.

References

Jain R, Chen Y, Kanno Y, Joyce-Shaikh B, Vahedi G, Hirahara K . Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells. Immunity. 2016; 44(1):131-142. PMC: 11608061. DOI: 10.1016/j.immuni.2015.11.009. View

Wertheimer T, Zwicky P, Rindlisbacher L, Sparano C, Vermeer M, Silva de Melo B . IL-23 stabilizes an effector T cell program in the tumor microenvironment. Nat Immunol. 2024; 25(3):512-524. PMC: 10907296. DOI: 10.1038/s41590-024-01755-7. View

Lee Y, Awasthi A, Yosef N, Quintana F, Xiao S, Peters A . Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012; 13(10):991-9. PMC: 3459594. DOI: 10.1038/ni.2416. View

Keles S, Charbonnier L, Kabaleeswaran V, Reisli I, Genel F, Gulez N . Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T17 cell differentiation. J Allergy Clin Immunol. 2016; 138(5):1384-1394.e2. PMC: 5099100. DOI: 10.1016/j.jaci.2016.04.023. View

Rogge L, Biffi M, Passini N, Presky D, Gubler U, Sinigaglia F . Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med. 1997; 185(5):825-31. PMC: 2196163. DOI: 10.1084/jem.185.5.825. View

Li Y, Zhu L, Chu Z, Yang T, Sun H, Yang F . Characterization and biological significance of IL-23-induced neutrophil polarization. Cell Mol Immunol. 2017; 15(5):518-530. PMC: 6068162. DOI: 10.1038/cmi.2017.39. View

Bao S, Zheng J, Li N, Huang C, Chen M, Cheng Q . Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage. Clin Res Hepatol Gastroenterol. 2017; 41(2):147-155. DOI: 10.1016/j.clinre.2016.10.005. View

Sun R, Abraham C . IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant. Cell Mol Gastroenterol Hepatol. 2020; 10(4):673-697. PMC: 7490566. DOI: 10.1016/j.jcmgh.2020.05.007. View

Floss D, Klocker T, Schroder J, Lamertz L, Mrotzek S, Strobl B . Defining the functional binding sites of interleukin 12 receptor β1 and interleukin 23 receptor to Janus kinases. Mol Biol Cell. 2016; 27(14):2301-16. PMC: 4945146. DOI: 10.1091/mbc.E14-12-1645. View

10.

Giuliani N, Airoldi I . Novel insights into the role of interleukin-27 and interleukin-23 in human malignant and normal plasma cells. Clin Cancer Res. 2011; 17(22):6963-70. DOI: 10.1158/1078-0432.CCR-11-1724. View

11.

Caruso R, Fina D, Paoluzi O, Del Vecchio Blanco G, Stolfi C, Rizzo A . IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol. 2008; 38(2):470-8. DOI: 10.1002/eji.200737635. View

12.

Alvarez J, Yasui D, Niida H, Joh T, Loh D, Kohwi-Shigematsu T . The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev. 2000; 14(5):521-35. PMC: 316425. View

13.

Sarin R, Wu X, Abraham C . Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci U S A. 2011; 108(23):9560-5. PMC: 3111257. DOI: 10.1073/pnas.1017854108. View

14.

Khatoon J, Prasad K, Rai R, Kumar Shukla S, Krishnani N, Ghoshal U . Expression levels of A disintegrin and metalloproteases (ADAMs), and Th17-related cytokines and their association with Helicobacter pylori infection in patients with gastroduodenal diseases. Pathog Dis. 2018; 76(8). DOI: 10.1093/femspd/fty078. View

15.

Yang B, Hagemann S, Mamareli P, Lauer U, Hoffmann U, Beckstette M . Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 2015; 9(2):444-57. DOI: 10.1038/mi.2015.74. View

16.

Langowski J, Zhang X, Wu L, Mattson J, Chen T, Smith K . IL-23 promotes tumour incidence and growth. Nature. 2006; 442(7101):461-5. DOI: 10.1038/nature04808. View

17.

Xu X, Yang C, Chen J, Liu J, Li P, Shi Y . Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway. Biochem Biophys Res Commun. 2018; 499(2):273-278. DOI: 10.1016/j.bbrc.2018.03.144. View

18.

Ribot J, Lopes N, Silva-Santos B . γδ T cells in tissue physiology and surveillance. Nat Rev Immunol. 2020; 21(4):221-232. DOI: 10.1038/s41577-020-00452-4. View

19.

Safrany E, Szabo M, Szell M, Kemeny L, Sumegi K, Melegh B . Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis. Inflamm Res. 2012; 62(2):195-200. DOI: 10.1007/s00011-012-0566-z. View

20.

Kasamatsu T, Kimoto M, Takahashi N, Minato Y, Gotoh N, Takizawa M . IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma. Hematol Oncol. 2017; 36(1):196-201. DOI: 10.1002/hon.2469. View